BioAssets Development Corporation (aka BDC) (Acquired) is Profiled in this Database

Updated At 25 Oct, 2011

Start Free 7 Day Trial Now
Partial description of this company
Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioAssets Development Corporation (aka BDC) (Acquired) plus 5035 other startups.

Start Free 7 Day Trial Now

Learn More About BioAssets Development Corporation (aka BDC) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png

The Medtech Pro Platform has Expanded! Request Demo